200 related articles for article (PubMed ID: 30184547)
1. Survival Benefit of Metformin Adjuvant Treatment For Pancreatic Cancer Patients: a Systematic Review and Meta-Analysis.
Wan G; Sun X; Li F; Wang X; Li C; Li H; Yu X; Cao F
Cell Physiol Biochem; 2018; 49(3):837-847. PubMed ID: 30184547
[TBL] [Abstract][Full Text] [Related]
2. Metformin therapy associated with survival benefit in lung cancer patients with diabetes.
Wan G; Yu X; Chen P; Wang X; Pan D; Wang X; Li L; Cai X; Cao F
Oncotarget; 2016 Jun; 7(23):35437-45. PubMed ID: 27105507
[TBL] [Abstract][Full Text] [Related]
3. Effect of Metformin and Statin Use on Survival in Pancreatic Cancer Patients: a Systematic Literature Review and Meta-analysis.
Jian-Yu E ; Graber JM; Lu SE; Lin Y; Lu-Yao G; Tan XL
Curr Med Chem; 2018; 25(22):2595-2607. PubMed ID: 28403788
[TBL] [Abstract][Full Text] [Related]
4. Relationships are between metformin use and survival in pancreatic cancer patients concurrent with diabetes: A systematic review and meta-analysis.
Shi YQ; Zhou XC; Du P; Yin MY; Xu L; Chen WJ; Xu CF
Medicine (Baltimore); 2020 Sep; 99(37):e21687. PubMed ID: 32925714
[TBL] [Abstract][Full Text] [Related]
5. No Effect of Metformin on Ovarian Cancer Survival: A Systematic Review and Meta-Analysis of Cohort Studies.
Wang Y; Liu X; Yan P; Bi Y; Liu Y; Zhang ZJ
Curr Pharm Des; 2019; 25(23):2595-2601. PubMed ID: 31333095
[TBL] [Abstract][Full Text] [Related]
6. Metformin as an adjuvant treatment for cancer: a systematic review and meta-analysis.
Coyle C; Cafferty FH; Vale C; Langley RE
Ann Oncol; 2016 Dec; 27(12):2184-2195. PubMed ID: 27681864
[TBL] [Abstract][Full Text] [Related]
7. Metformin is associated with survival benefit in pancreatic cancer patients with diabetes: a systematic review and meta-analysis.
Zhou PT; Li B; Liu FR; Zhang MC; Wang Q; Li YY; Xu C; Liu YH; Yao Y; Li D
Oncotarget; 2017 Apr; 8(15):25242-25250. PubMed ID: 28445955
[TBL] [Abstract][Full Text] [Related]
8. The effect of metformin on survival of patients with pancreatic cancer: a meta-analysis.
Li X; Li T; Liu Z; Gou S; Wang C
Sci Rep; 2017 Jul; 7(1):5825. PubMed ID: 28724893
[TBL] [Abstract][Full Text] [Related]
9. Prognostic role of metformin intake in diabetic patients with colorectal cancer: An updated qualitative evidence of cohort studies.
Du L; Wang M; Kang Y; Li B; Guo M; Cheng Z; Bi C
Oncotarget; 2017 Apr; 8(16):26448-26459. PubMed ID: 28103573
[TBL] [Abstract][Full Text] [Related]
10. Relationship Between Metformin Use and Recurrence and Survival in Patients With Resected Stage III Colon Cancer Receiving Adjuvant Chemotherapy: Results From North Central Cancer Treatment Group N0147 (Alliance).
Singh PP; Shi Q; Foster NR; Grothey A; Nair SG; Chan E; Shields AF; Goldberg RM; Gill S; Kahlenberg MS; Sinicrope FA; Sargent DJ; Alberts SR
Oncologist; 2016 Dec; 21(12):1509-1521. PubMed ID: 27881709
[TBL] [Abstract][Full Text] [Related]
11. Survival Benefit of Metformin as an Adjuvant Treatment for Head and Neck Cancer: A Systematic Review and Meta-Analysis.
Jiao Y; Liu D; Sun Y; Chen Z; Liu S
Front Pharmacol; 2022; 13():850750. PubMed ID: 35645803
[No Abstract] [Full Text] [Related]
12. Metformin may improve the prognosis of patients with pancreatic cancer.
Zhang JW; Sun Q
Asian Pac J Cancer Prev; 2015; 16(9):3937-40. PubMed ID: 25987064
[TBL] [Abstract][Full Text] [Related]
13. The impact of metformin use on survival in kidney cancer patients with diabetes: a meta-analysis.
Li Y; Hu L; Xia Q; Yuan Y; Mi Y
Int Urol Nephrol; 2017 Jun; 49(6):975-981. PubMed ID: 28271326
[TBL] [Abstract][Full Text] [Related]
14. The effectiveness of adjuvant chemotherapy for Stage I pancreatic cancer based on the UICC 8
Hamura R; Haruki K; Fujiwara Y; Tsunematsu M; Shirai Y; Furukawa K; Onda S; Gocho T; Shiba H; Uwagawa T; Usuba T; Fujioka S; Okamoto T; Ikegami T
Langenbecks Arch Surg; 2022 Dec; 407(8):3437-3446. PubMed ID: 36173461
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of anti-diabetic medications in pancreatic cancer: A meta-analysis.
Zhou DC; Gong H; Tan CQ; Luo JQ
Oncotarget; 2017 Sep; 8(37):62349-62357. PubMed ID: 28977950
[TBL] [Abstract][Full Text] [Related]
16. Differential and Joint Effects of Metformin and Statins on Overall Survival of Elderly Patients with Pancreatic Adenocarcinoma: A Large Population-Based Study.
E JY; Lu SE; Lin Y; Graber JM; Rotter D; Zhang L; Petersen GM; Demissie K; Lu-Yao G; Tan XL
Cancer Epidemiol Biomarkers Prev; 2017 Aug; 26(8):1225-1232. PubMed ID: 28619830
[No Abstract] [Full Text] [Related]
17. The Impact of Diabetes Mellitus and Metformin Treatment on Survival of Patients with Advanced Pancreatic Cancer Undergoing Chemotherapy.
Choi Y; Kim TY; Oh DY; Lee KH; Han SW; Im SA; Kim TY; Bang YJ
Cancer Res Treat; 2016 Jan; 48(1):171-9. PubMed ID: 25779362
[TBL] [Abstract][Full Text] [Related]
18. Metformin Use Is Associated With Better Survival of Breast Cancer Patients With Diabetes: A Meta-Analysis.
Xu H; Chen K; Jia X; Tian Y; Dai Y; Li D; Xie J; Tao M; Mao Y
Oncologist; 2015 Nov; 20(11):1236-44. PubMed ID: 26446233
[TBL] [Abstract][Full Text] [Related]
19. The importance of time-to-adjuvant treatment on survival with pancreatic cancer: A systematic review and meta-analysis.
Sugumar K; Hue JJ; De La Serna S; Rothermel LD; Ocuin LM; Hardacre JM; Ammori JB; Winter JM
Cancer Rep (Hoboken); 2021 Oct; 4(5):e1390. PubMed ID: 34245139
[TBL] [Abstract][Full Text] [Related]
20. Metformin use and survival of lung cancer patients: Meta-analysis findings.
Zhong S; Wu Y; Yan X; Tang J; Zhao J
Indian J Cancer; 2017; 54(1):63-67. PubMed ID: 29199666
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
